Extended Pouch Roux-en-Y Gastric Bypass Study
Extended Pouch Roux-en-Y Gastric Bypass Study
Morbid obesity is an increasing medical problem in the western countries. It's related to
 comorbidities as diabetes mellitus, hypertension, OSAS, arthrosis and hypercholesterolemia.
 The Roux-en-Y Gastric Bypass (RYGB) is an effective surgical therapy for morbidly obese
 patients. A part of these patients will have disappointing results, and have weight regain on
 the long term. Some studies show more weight reduction by increasing the biliopancreatic limb
 in patients with morbid obesity.

 The objective of this study is to investigate the effect of a restrictive/extended pouch on
 weight reduction in morbidly obese patients undergoing RYGB-surgery. We hypothesize that the
 restrictive/extended pouch results in more weight reduction.

 The study design is a prospective, randomized control trial. The patients will be randomized
 in 2 groups: a standard RYGB (normal pouch) and restrictive/extended pouch RYGB.
Inclusion Criteria:

 Patient eligible for bariatric surgery according Fried guidelines

 Primary Gastric bypass

 -  BMI 35 - 40 with a comorbidity

 -  or BMI > 40

 Exclusion Criteria:

 -  Exclusion criteria for bariatric surgery (Fried Guidelines)

 -  Patients with language problems that interveins to follow medical advises

 -  Genetic diseases that intervens to follow medical advises

 -  Chronic bowel diseases

 -  Nephrologic (MDRD <30) of liver diseases (AST/ALT more than twice the norm)

 -  Pregnancy